Myricetin prevents tumor development by promoting apoptosis through intrinsic and extrinsic pathways by networking with oncoproteins such as Akt, MEK1, Fyn, and JAK1-STAT3, thereby attenuating the neoplastic alteration of tumor cells [116]. Here, MAP2K1 is linked to neoplasm.